Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 4Stomach Neoplasms 3Uterine Cervical Neoplasms 1Smoking 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Platelet Glycoprotein IV Deficiency 1Pediatric Brain Tumor 1Pancreatic Cyst 1Ovarian Neoplasms 1Osteosarcoma 1Neuroendocrine Tumors 1Neoplasms 1Melanoma 1Lymphoma 1Locally Advanced Pancreatic Cancer 1Gastrointestinal Neoplasms 1Fatty Liver 1Cysts 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Cyclophosphamide 23venetoclax 17Dexamethasone 16pembrolizumab 15fludarabine 15Cytarabine 13pomalidomide 8Rituximab 8Gemcitabine 8Carboplatin 8Azacitidine 8glofitamab 7fludarabine phosphate 7Lenalidomide 7selinexor 6Paclitaxel 6Injections 6Immunotherapy, Adoptive 6Granulocyte Colony-Stimulating Factor 6Cisplatin 6daratumumab 5Temozolomide 5Bevacizumab 5zanubrutinib 4ruxolitinib 4Surgical Procedures, Operative 4Oxaliplatin 4Nivolumab 4Drug Therapy 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Recurrence × Tomography, X-Ray Computed × Clear all
NCT04740346 2021-10-27

Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)

National Cancer Center, Korea

Phase NA Recruiting
886 enrolled
Gastrointestinal

Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡